Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Professional Development And Leadership topic
No spam. Unsubscribe anytime.
Board holds first-time manager orientation, approves diversion CE; drug control director to leave Sept. 2
Summary
The Connecticut Board of Pharmacy presented a first-time pharmacy manager orientation, approved a continuing-education program on diversion prevention and accepted Director Rod Marriott's announcement that his last day will be Sept. 2.
The Connecticut Board of Pharmacy used its Aug. 27 meeting to hold a first-time pharmacy manager orientation, to approve a continuing-education course on diversion prevention and to hear an announced leadership transition in the department.
The chair addressed newly named pharmacy managers in person, describing managerial responsibilities and common inspection findings. "You are the person responsible for that pharmacy and everyone that works in that box," the chair told first-time managers, and reminded them that a manager "must appear before the board before you're a pharmacy manager." The chair stressed a 35-hour-per-week minimum presence for pharmacy managers, the importance of tracking license expirations and continuing education, and adherence to technician ratios.
Commissioner Marion Guante and Director Rod Marriott introduced a one-hour, live continuing-education course titled "New laws and best practices for preventing and identifying diversion." Director Marriott said the topic aligns with the department's enforcement priorities and compounding oversight. The board approved the program by voice vote.
During his report Director Rod Marriott announced to the board, "this will be my last meeting, as director of drug control. Moving on, my last day will be September 2." Marriott reviewed current and planned agency initiatives, including a drug-shortage task force and a pharmacy-compensation task force intended to examine payment for expanded pharmacist services. He also encouraged licensees to sign up for FDA MedWatch alerts and to maintain routine reporting practices.
The orientation covered practical inspection-focused advice: keep accurate perpetual inventories, reconcile scheduled controlled substances monthly, document misfills promptly, ensure technicians and clerks carry proper identification, confirm robotics and automated systems are calibrated, and notify the department of closings or changes to posted hours. Commissioners emphasized resources for pharmacists, including professional associations and an anonymous support program (Haven Health) for mental-health or substance-use concerns.
The board recorded the CE approval and thanked Director Marriott for his service. Staff indicated the approved CE will be scheduled and promoted to licensees through the usual channels.
